Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 23.24.
Forward PE Ratio (23.24) = Close Price ($34.60) / Consensus Forward EPS ($1.49)
FORWARD PE RATIO
23.24
SECTOR MEDIAN · HEALTHCARE
19.84
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+17.17%
vs the sector median at left
Medline Inc.
Market Cap
$29.25B
Forward PE Ratio
23.24
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Medline Inc. (MDLN) | $29.25B | 23.24 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.00B | 13.56 |
| Waters Corporation (WAT)vs › | $30.63B | 27.65 |
| Zoetis Inc. (ZTS)vs › | $30.85B | 11.76 |
| Biogen Inc. (BIIB)vs › | $31.38B | 17.02 |
| Centene Corp. (CNC)vs › | $31.61B | 13.45 |
| ResMed Inc. (RMD)vs › | $31.95B | 19.87 |
| DexCom, Inc. (DXCM)vs › | $31.99B | 31.69 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.37B | 28.01 |
| Labcorp Holdings Inc. (LH)vs › | $26.30B | 17.70 |
Trailing P/E
40.3
reported TTM EPS
Forward P/E
23.2
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.49 implies +73.3% EPS growth vs the reported trailing $0.86.
At today's $34.60 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.49 | $1.35 – $1.55 | 12 | 23.2x |
| 2027-12-31 | $1.57 | $1.48 – $1.67 | 15 | 22.0x |
| 2028-12-31 | $1.80 | $1.26 – $2.02 | 8 | 19.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute